pharma

Pharma sector poised to grow at 9% through FY30: Care Ratings

In the exports segment, as per Care Ratings, the regulated markets (US, European Union) are expected to maintain strong growth…

October 16, 2025 22:38 IST

Market Watchlist: Will earnings spark the breakout everyone’s waiting for? HDFC Bank, Tata Steel, Bajaj Finance among 9 stocks to watch

Market watchlist this week, October 12: Track key stocks like HDFC Bank, Tata Steel, and Bajaj Finance as earnings season…

October 13, 2025 05:30 IST

India's Revised PRIP Scheme: A Boost for Pharma R&D or Still Falling Short of Novel Drug Dreams?

Faster GST refunds a boon for pharma and MedTech units

In early September, the government slashed GST rates on all pharmaceutical formulations from 12% to 5%. Exemptions were also provided…

October 10, 2025 23:21 IST

Meet India’s new rich: Younger, bolder, and building from scratch

With 1,115 self-made entrepreneurs and 358 billionaires, India’s new rich are rewriting the rules of wealth creation. From AI founders…

October 8, 2025 05:30 IST

Pharma Stocks Slump on US 100% Tariff News, But Experts Say Generic Exports are Safe.

Explainer: PRIP can be the magic pill for drug discovery

Enhancing intellectual property enforcement and offering tax benefits on R&D expenditure can further motivate innovators. Skill development programmes for scientists,…

October 7, 2025 21:20 IST

Indegene stock, ICICI Securities Add rating

Indegene buys BioPharm for $106 mn to boost AI-driven pharma marketing

The deal, executed through Indegene’s subsidiary ILSL Inc., aims to strengthen Indegene’s commercialisation portfolio and expand its AI-powered marketing and…

October 2, 2025 09:42 IST

US tariff on Indian pharma: Nomura sees $100 million tariff risk for Sun Pharma

Nomura warns Sun Pharma faces $100 million risk from potential US tariffs on specialty drugs. Explore the impact on Indian…

September 30, 2025 17:54 IST

Trump built a tariff wall, Indian pharma found a European gate

Large Indian generic exporters are expanding their presence in European markets via a spate of acquisitions in that region, at…

September 30, 2025 05:00 IST

Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV

Lupin buys Amsterdam-based VISUfarma for Euro 190 million to boost speciality eye care portfolio

Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.

September 29, 2025 10:43 IST

ICICI Lombard Dividend 2025: Check record date, eligibility, and other key details

Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week

Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…

September 28, 2025 07:00 IST

IT, pharma drag indices dower, investors’ wealth erodes by Rs 15.2 lakh crore

Indian benchmark indices, Sensex and Nifty, extended their losing streak to a sixth session on Friday, dropping nearly 1% and…

September 26, 2025 23:11 IST

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

Natco Pharma is going to demerge its agro business from the core pharmaceutical business.

Natco Pharma demerger plan approved by board: What it means for agro and core pharma business

Natco Pharma plans to demerge its agro business from core pharma to unlock value, enhance focus, and ensure dedicated management.

September 25, 2025 12:05 IST

Nomura on Glenmark Pharma today, September 25

More pain ahead for Glenmark Pharma? 3 reasons why Nomura sees 25% downside after licencing deal for cancer drug

Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!

September 25, 2025 10:54 IST

Re-labelling not mandatory; GST benefits on medicines from Sept 22

Govt says relabelling for medicine packs not mandatory, manufacturers must issue a revised price list

Government clarifies re-labelling of medicines is not mandatory as new GST rates take effect from September 22.

Updated: September 16, 2025 16:33 IST

Trump’s tariff pivot: Signs order to exempt over 45 import categories-From gold, nickel, pharma, see what’s covered

His latest order identifies more than 45 categories for zero import tariffs from “aligned partners” who clinch framework pacts to…

Updated: September 6, 2025 10:13 IST

Waaree Renewable Technologies Limited, Adani Energy Solutions Limited, adani group

The truth behind India’s top 3 fastest-growing companies

With increasing government policy support, innovation, and digitalisation, many Indian businesses are growing at a fast pace. Here are three…

September 2, 2025 05:20 IST

JM Financial Piramal Pharma target price, Piramal Pharma share price

India’s contract drugs manufacturing set to grow at 18%: Jefferies

India’s $3 bn contract research, development and manufacturing (CRDMO) sector is set to grow at 18% CAGR till FY30, says…

August 26, 2025 22:22 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar linking and KYC rules explained

UK immigration new rules, Skilled Worker visa changes, Graduate visa months, UK visa reforms, High Potential Individual route, UK student visa rules, UK Visa English requirement

UK announces major changes in immigration rules for overseas students and foreign workers

Green card holders, 2025 Naturalization Civics Test full list, 2025 civics test, U.S. citizenship, naturalization process, US immigration policy, new naturalization civics test 2025, USCIS 2025 citizenship test

US announces 2025 civics test for green card holders starting today

Mappls vs Google Maps: 5 standout features of India’s homegrown navigation app

H-1B denied to F-1 holder despite lottery selection, USCIS issues surprise rejection

Expect loan, deposit growth at 18-20% in FY26: DCB Bank MD

Business6 hr ago

DCB Bank is targeting a growth of 18-20% in loans and deposits this year, with a reported loan growth of 19.14% and deposit growth of 18.8%. The recent GST reforms and repo rate cut have boosted expectations and impacted consumer behavior. The bank’s focus is on secured, small-ticket lending to SMEs and becoming a full-fledged financial partner. They also aim to reduce slippages.

View all shorts